Targeted Therapy Directed by Genetic Testing in Treating Patients With Advanced Refractory Solid Tumors, Lymphomas, or Multiple Myeloma (The MATCH Screening Trial)
National Cancer Institute (NCI)
National Cancer Institute (NCI)
City of Hope Medical Center
University of Nebraska
Natera, Inc.
Novartis
Massive Bio, Inc.
UNC Lineberger Comprehensive Cancer Center
Guardant Health, Inc.
Columbia University
University of Arizona
Tempus AI